Steven Kelly

CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.

Kelly Bioconsulting LLC provides business consulting services. The private company is based in Boulder.

Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.

Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA.

The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America.

BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.